David Millar is calling on the World Anti-Doping Agency (WADA) to completely ban the corticosteroid used by Sir Bradley Wiggins during his time with Team Sky, calling the drug "powerful" and "destructive".
In a data leak last week it was revealed that Wiggins received six therapeutic use exemptions (TUEs) during his career, three for triamcinolone, which was used to treat a pollen allergy.
In an interview with the Telegraph's Tom Cary, Millar described his experience of the drug, saying Kenacort – a trade name for triamcinolone - "put you on this weird high”, having used it himself in the past.
The former Garmin professional, who served a two year ban for drug use in his early career and is now an active anti-doping campaigner, did not comment on the Wiggins case, but shared his experience of Kenacort.
“You would do all the training but my weight would stick,” he said, referencing his own use of EPO and testosterone patches. “But if I took Kenacort, 1.5-2kgs would drop off in like a week. And not only would the weight drop off I would feel stronger.
“If you are non-asthmatic and you take Ventolin it’s not going to give you any advantage. But if you take Kenacort it’s not only going to make a sick person better, it’s going to make a sick person better than a healthy person. That’s a very grey area.
“I’m sure there are other forms of cortisone that could be used for allergies which aren’t so potent or performance-enhancing.” He added: “We [athletes] shouldn’t have to face this. If it’s that strong we shouldn’t be allowed to take it unless there is a serious issue.
"And if we’re suffering from that serious an issue, we shouldn’t be racing. I don’t know how a doctor could prescribe it [before a race]. I can’t fathom it.”
In a statement released on Wiggins's behalf following the data leak, it was insisted there was "nothing new" in the revelations, which have left the 2012 Tour champion under fire due to his his previous statements regarding Team Sky's 'no-needle' policy.
“The triamcinolone injection that is referred to in the WADA leaks is an intramuscular treatment for asthma and is fully approved by the sport’s governing bodies," the statement read.
Thank you for reading 5 articles this month* Join now for unlimited access
Enjoy your first month for just £1 / $1 / €1
*Read 5 free articles per month without a subscription
Join now for unlimited access
Try first month for just £1 / $1 / €1
Stuart Clarke is a News Associates trained journalist who has worked for the likes of the British Olympic Associate, British Rowing and the England and Wales Cricket Board, and of course Cycling Weekly. His work at Cycling Weekly has focused upon professional racing, following the World Tour races and its characters.
The Schwalbe G-One RS gravel tire: a season-long review
We rode and tested the new Schwalbe G-One RS gravel tire all season long and loved it.
By Anne-Marije Rook • Published
Remco Evenepoel set for Grand Place celebrations after hero's welcome home
Message from Sir Dave Brailsford suggests Ineos Grenadiers are also interested in the world champion
By James Shrubsall • Published
Egan Bernal ends season to return to Colombia for knee surgery
No Il Lombardia or Tour of Croatia for the Colombian as he builds for 2023 comeback
By Tom Thewlis • Published
Adam Yates leaves Ineos Grenadiers for UAE Team Emirates
British rider agrees three year deal with new team
By Tom Thewlis • Published